SE8302171L - Forfarande for framstellning av nya acetohydroxamsyror - Google Patents

Forfarande for framstellning av nya acetohydroxamsyror

Info

Publication number
SE8302171L
SE8302171L SE8302171A SE8302171A SE8302171L SE 8302171 L SE8302171 L SE 8302171L SE 8302171 A SE8302171 A SE 8302171A SE 8302171 A SE8302171 A SE 8302171A SE 8302171 L SE8302171 L SE 8302171L
Authority
SE
Sweden
Prior art keywords
alkyl
formula
cycloalkyl
optionally substituted
preparation
Prior art date
Application number
SE8302171A
Other languages
English (en)
Other versions
SE8302171D0 (sv
SE452155B (sv
Inventor
L Lafon
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Publication of SE8302171D0 publication Critical patent/SE8302171D0/sv
Publication of SE8302171L publication Critical patent/SE8302171L/sv
Publication of SE452155B publication Critical patent/SE452155B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/72—Acyl halides containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/22—[b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/56—Radicals substituted by sulfur atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Claims (1)

PATENTKRAV
1. Analogiforfarande for framstallning av terapeutiskt verksamma arylsulfinylacetohydroxamsYraderivat med den allmAnna formeln: F,(2,,0 z - CH2 - SO - CH - C7,NHoti i vilken 112 betecknar vate eller en CI-C6alkylgrupp, och Z betecknar en a-naftylgrupp eller en fenylgrupp som kan vara substituerad med en eller flera C1-C4-alkoxigrupper, halogenatomer eller nitrogrupper, eller en metylendtoxigrupp, samt deras metallsalter och syraadditionssalter, kAnnetecknatdArav, att ett Attiksyradertvat med formeln: Z - CC2 - - CH - CO - Z. i vilken R2 och Z har den ovan angivna betydelsen, och Z. betecknar en halogenatom eller en C1-C3-alkoxIgrupp, bringas att reagera mod hydroxylamin for erhAllav en tioaceo...ydroxamsyra med formeln: z - CH2 - 5 - CH - C5 vilken R2 och Z har den oven angivna betydelsen, vilken oxideras for erhallande av det motsvarande sulfinylderivatet med formeln I. (I)
SE8302171A 1976-03-23 1983-04-19 Analogiforfarande for framstellning av terapeutiskt verksamma arylsulfinylacetohydroxamsyraderivat SE452155B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB11710/76A GB1574822A (en) 1976-03-23 1976-03-23 Acetohydroxamic acid derivatives and pharmaceutical compositions thereof
GB629877 1977-02-15

Publications (3)

Publication Number Publication Date
SE8302171D0 SE8302171D0 (sv) 1983-04-19
SE8302171L true SE8302171L (sv) 1983-04-19
SE452155B SE452155B (sv) 1987-11-16

Family

ID=26240593

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7703263A SE432420B (sv) 1976-03-23 1977-03-22 Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror
SE8302171A SE452155B (sv) 1976-03-23 1983-04-19 Analogiforfarande for framstellning av terapeutiskt verksamma arylsulfinylacetohydroxamsyraderivat
SE8302172A SE458605B (sv) 1976-03-23 1983-04-19 Foerfarande foer framstaellning av acetohydroxamsyror
SE8302173A SE456992B (sv) 1976-03-23 1983-04-19 Foerfarande foer framstaellning av 2-(1-fenyl-bensimidazolyl)-acetohydroxamsyra

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7703263A SE432420B (sv) 1976-03-23 1977-03-22 Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE8302172A SE458605B (sv) 1976-03-23 1983-04-19 Foerfarande foer framstaellning av acetohydroxamsyror
SE8302173A SE456992B (sv) 1976-03-23 1983-04-19 Foerfarande foer framstaellning av 2-(1-fenyl-bensimidazolyl)-acetohydroxamsyra

Country Status (25)

Country Link
US (7) US4122186A (sv)
JP (1) JPS52144601A (sv)
AT (5) AT356078B (sv)
AU (1) AU516473B2 (sv)
BE (1) BE852738A (sv)
CA (2) CA1120928A (sv)
CH (1) CH620894A5 (sv)
CS (1) CS200511B2 (sv)
DD (1) DD129645A5 (sv)
DE (1) DE2711451A1 (sv)
DK (1) DK171197B1 (sv)
ES (1) ES457105A1 (sv)
FI (1) FI62821C (sv)
FR (4) FR2345430A1 (sv)
GB (1) GB1574822A (sv)
IE (1) IE44721B1 (sv)
IL (1) IL51705A (sv)
LU (1) LU76989A1 (sv)
NL (1) NL188801C (sv)
NO (4) NO144420C (sv)
NZ (1) NZ183616A (sv)
PH (1) PH16271A (sv)
PT (1) PT66300B (sv)
SE (4) SE432420B (sv)
SU (1) SU689617A3 (sv)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
US4405357A (en) 1980-06-02 1983-09-20 Fmc Corporation Herbicidal 3-isoxazolidinones and hydroxamic acids
FR2502617B1 (sv) * 1981-03-25 1984-04-27 Lafon Labor
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
JPS59222454A (ja) * 1983-05-31 1984-12-14 Ajinomoto Co Inc アミノ酸の製造方法
US4604407A (en) * 1985-04-04 1986-08-05 E. R. Squibb & Sons, Inc. Hydroxamates
FR2584666B1 (fr) * 1985-07-10 1989-06-16 Champion Spark Plug Europ Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2585699B1 (fr) * 1985-07-31 1988-03-11 Lafon Labor Derive d'acide acetohydroxamique, procede de preparation et utilisation en therapeutique
US5036157A (en) * 1986-03-11 1991-07-30 Burroughs Wellcome Co. Aryl derivatives
FR2601673B2 (fr) * 1986-07-21 1989-06-02 Lafon Labor Derives de l'acetamide et medicaments qui en contiennent
US4983567A (en) * 1987-03-16 1991-01-08 Biomeasure, Inc. Immunomodulators and methods of making same
ES2011588A6 (es) * 1989-05-29 1990-01-16 Vinas Lab Procedimiento para la preparacion de un nuevo derivado fenilacetico.
JPH0359402U (sv) * 1989-10-13 1991-06-12
CA2028530A1 (en) * 1989-11-21 1991-05-22 Christian Hubschwerlen Substituted pyrimidobenzimidazole derivatives
US5283248A (en) * 1989-11-21 1994-02-01 Hoffmann-La Roche Inc. Amino substituted pyrimido[1,6-2]benzimidazoles
US5378701A (en) * 1991-12-27 1995-01-03 Kyowa Hakko Kogyo Tricyclic compounds
US6060477A (en) * 1995-06-07 2000-05-09 Cell Pathways, Inc. Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
GEP20022626B (en) * 1997-02-27 2002-02-25 American Cyanamid Company Us N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl Sulfanyl, Sulfinil or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase Inhibitors
US6172057B1 (en) 1997-02-27 2001-01-09 American Cyanamid Company N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
US6187924B1 (en) * 1997-11-12 2001-02-13 Darwin Discovery, Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
PE20001566A1 (es) 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
GB9911071D0 (en) * 1999-05-12 1999-07-14 Darwin Discovery Ltd Hydroxamic and carboxylic acid derivatives
AU2002365650A1 (en) * 2001-12-04 2003-06-17 De Novo Pharmaceuticals Limited Bacterial enzyme inhibitors
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
US7842835B2 (en) * 2003-07-07 2010-11-30 Georgetown University Histone deacetylase inhibitors and methods of use thereof
EP1644323B1 (en) * 2003-07-07 2015-03-18 Georgetown University Histone deacetylase inhibitors and methods of use thereof
US7417040B2 (en) * 2004-03-01 2008-08-26 Bristol-Myers Squibb Company Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
US7378426B2 (en) * 2004-03-01 2008-05-27 Bristol-Myers Squibb Company Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3
WO2007134169A2 (en) * 2006-05-10 2007-11-22 Nuada, Llc Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
US20090264384A1 (en) * 2004-11-01 2009-10-22 Nuada, Inc. Indole, benzimidazole, and benzolactam boronic acid compounds, analogs thereof and methods of use thereof
WO2007113644A2 (en) * 2006-04-05 2007-10-11 Orchid Research Laboratories Limited New hdac inhibitors
SG172685A1 (en) 2006-06-28 2011-07-28 Amgen Inc Glycine transporter-1 inhibitors
CA2663569A1 (en) * 2006-09-28 2008-04-03 Merck & Co., Inc. Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitor chelate complexes
EP2049483A2 (en) * 2006-10-28 2009-04-22 Methylgene, Inc. Inhibitors of histone deacetylase
US8242174B2 (en) 2007-02-01 2012-08-14 Panthera Biopharma Llc Hydroxamic acid derivatives of aniline useful as therapeutic agents for treating anthrax poisoning
FR2957492B1 (fr) 2010-03-18 2013-08-16 Rhodia Operations Nouvelles utilisations de composes de type esteramide
CN101982459A (zh) * 2010-10-21 2011-03-02 山东华尔康生物技术有限公司 乙酰氧肟酸的制备工艺
GB201509663D0 (en) * 2015-06-03 2015-07-15 Johnson Matthey Plc Benzo(h)quinoline ligands and complexes thereof
US11993575B1 (en) 2023-12-29 2024-05-28 King Faisal University Ethyl [4,4-bis(4-bromophenyl)-2,5-dioxoimidazolidin-1-yl]acetate as an antimicrobial compound
US11970462B1 (en) 2024-01-03 2024-04-30 King Faisal University Ethyl 3-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]propanoate as an antimicrobial compound
US12172968B1 (en) 2024-01-25 2024-12-24 King Faisal University 4-[4,4-bis(4-chlorophenyl)-2,5-dioxoimidazolidin-1-yl]butanoic acid as an antimicrobial compound

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2862020A (en) * 1958-11-25 Derivatives of a-amino-p-hydroxy
US2279560A (en) * 1940-05-08 1942-04-14 Du Pont Viscous hydrocarbon oil
US2397508A (en) * 1943-05-29 1946-04-02 Standard Oil Co Hydroxamic acids
GB894119A (en) * 1959-11-02 1962-04-18 Ici Ltd Pivalic acid derivative
US3275643A (en) * 1963-07-19 1966-09-27 Irwin I Lubowe Allantoin-pantothenate compounds
US3634509A (en) * 1966-06-08 1972-01-11 Shell Oil Co 2 6-dinitroanilinoacetamides
NL6715600A (sv) * 1966-12-02 1968-06-04
US3927092A (en) * 1968-06-24 1975-12-16 Merck & Co Inc Amides of 2-{8 halophenoxy (or halophenylthio){9 -alkanoic acids
DE1805548A1 (de) * 1968-10-26 1970-10-08 Agfa Gevaert Ag Benzimidazol-Derivate und ihre photographische Verwendung
FR2036953A1 (en) * 1969-04-23 1970-12-31 Pluripharm Diphenylhydantoin derivs
US4092430A (en) * 1970-09-09 1978-05-30 Ciba-Geigy Corporation Antiphlogistic phenylacetohydroxamic acid compositions
US3728380A (en) * 1971-05-17 1973-04-17 Morton Norwich Products Inc P-chlorobenzamidoacetohydroxamic acid
US3839580A (en) * 1972-08-14 1974-10-01 Morton Norwich Products Inc 2-p-(nitrobenzamido)acetohydroxamic for treating urinary tract infections
SE7411007L (sv) * 1973-10-10 1975-04-11 Ciba Geigy Ag
JPS51102636A (en) * 1974-04-03 1976-09-10 Fuji Photo Film Co Ltd Karaashashingazo no keiseihoho
FR2285859A1 (fr) * 1974-09-30 1976-04-23 Lafon Labor Phenylsulfinyl-amidines et derives
CH593954A5 (sv) * 1975-07-21 1977-12-30 Ciba Geigy Ag
US4029812A (en) * 1976-02-18 1977-06-14 The Dow Chemical Company Novel hypolipidemic 2-(3,5-di-tert-butyl-4-hydroxyphenyl)thio carboxamides

Also Published As

Publication number Publication date
DK126677A (da) 1977-09-24
ATA840078A (de) 1980-11-15
IE44721B1 (en) 1982-03-10
BE852738A (fr) 1977-09-22
AU2334477A (en) 1978-09-21
LU76989A1 (sv) 1977-07-18
ES457105A1 (es) 1978-10-16
SE8302171D0 (sv) 1983-04-19
AT374191B (de) 1984-03-26
FR2453133B1 (sv) 1984-04-06
IE44721L (en) 1977-09-23
SU689617A3 (ru) 1979-09-30
AT356078B (de) 1980-04-10
FR2453148A1 (fr) 1980-10-31
FR2453158B1 (sv) 1982-08-06
US4209524A (en) 1980-06-24
FR2453158A1 (fr) 1980-10-31
NO152972C (no) 1985-12-27
IL51705A (en) 1982-09-30
SE456992B (sv) 1988-11-21
FR2345430A1 (fr) 1977-10-21
NO145881C (no) 1982-06-16
NO146431C (no) 1982-09-29
ATA839978A (de) 1980-02-15
PT66300B (pt) 1978-08-10
CH620894A5 (sv) 1980-12-31
NO152972B (no) 1985-09-16
IL51705A0 (en) 1977-05-31
AT362793B (de) 1981-06-10
NO144420B (no) 1981-05-18
AT361932B (de) 1981-04-10
AU516473B2 (en) 1981-06-04
FI770859A7 (sv) 1977-09-24
ATA501480A (de) 1983-08-15
US4151300A (en) 1979-04-24
SE7703263L (sv) 1977-09-24
SE8302172L (sv) 1983-04-19
JPS628424B2 (sv) 1987-02-23
NZ183616A (en) 1979-03-28
FR2453148B1 (sv) 1983-12-02
NO144420C (no) 1981-08-26
NO145881B (no) 1982-03-08
FI62821B (fi) 1982-11-30
SE452155B (sv) 1987-11-16
NO771006L (no) 1977-09-26
GB1574822A (en) 1980-09-10
NO803336L (no) 1977-09-26
FR2345430B1 (sv) 1982-07-23
NO146431B (no) 1982-06-21
US4122186A (en) 1978-10-24
FR2453133A1 (fr) 1980-10-31
FI62821C (fi) 1983-03-10
US4225617A (en) 1980-09-30
SE8302172D0 (sv) 1983-04-19
ATA193077A (de) 1979-09-15
ATA839878A (de) 1980-09-15
NO803337L (no) 1977-09-26
SE8302173L (sv) 1983-04-19
CA1120928A (en) 1982-03-30
DE2711451A1 (de) 1977-10-06
CS200511B2 (en) 1980-09-15
SE458605B (sv) 1989-04-17
DK171197B1 (da) 1996-07-22
SE432420B (sv) 1984-04-02
SE8302173D0 (sv) 1983-04-19
US4183951A (en) 1980-01-15
NL7703168A (nl) 1977-09-27
PT66300A (fr) 1977-04-01
NO803338L (no) 1977-09-26
AT358556B (de) 1980-09-25
US4152458A (en) 1979-05-01
DD129645A5 (de) 1978-02-01
CA1130301A (en) 1982-08-24
NL188801C (nl) 1992-10-01
PH16271A (en) 1983-08-25
US4209523A (en) 1980-06-24
JPS52144601A (en) 1977-12-02
DE2711451C2 (sv) 1990-05-10

Similar Documents

Publication Publication Date Title
SE8302173L (sv) Forfarande for framstellning av nya acetohydroxamsyror
ES8102559A1 (es) Un procedimiento para la preparacion de la forma racemica y de las formas esteroisomeras de ellas de un derivado del a- cido 1,2,3,4-tetrahidro-2-quinolincarboxilico
ES8802523A1 (es) Procedimiento para prepara nuevos acidos tieno-triazolo-1,4-diazepino-2-carboxilicos
ATE83485T1 (de) Chinuclidinderivate.
ES8303382A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
IT1063628B (it) Procedimento per la produzione di alogenuri di acidi beta alogenoformil etil fosfinici
ES8204415A1 (es) Un procedimiento para la preparacion de derivados de carboximidamida.
ES8601183A1 (es) Procedimiento para preparar derivados de acidos 1-oxido-1, 2-ditiolano-carboxilicos
ES516362A0 (es) "procedimiento para la preparacion de un oligomero de un disocianato alifatico".
JPS5212141A (en) Novel amino benzoic acid derivatives, their preparation, and pharmaceu tical compositions therefrom
ES8300722A1 (es) Procedimiento para la preparacion de carbamoiloxiamino-1,4- benzodiazepinas
DE3876546D1 (de) Ethanon-oxime.
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos
GB811268A (en) Sulphinyl-phosphoric acid esters and a process for their production
SE8006413L (sv) Nya cefalosporiner
GB1147295A (en) Process for the production of bis-quaternary ammonium compounds
ES8104248A1 (es) Procedimiento de preparacion de 6-amino-sustituidas-3-piri- dazinilhidrazinas y de sus sales de adicion acidas terapeu- ticamente aceptables
JPS5227757A (en) Preparation of 6-aminomethylnaphthalene derivatives
FR1602630A (en) Alpha-subst hydrocinnamic acid derivatives for reducing
GB1385171A (en) C-sulphonyl and c-sulphenyl substituted amides
GB1442505A (en) Optically active n,n-dialkyl-n,n-bis-1-hydroxybutyl-2-ethylene diamine esters and salts thereof with acids
DK152733C (da) (d)-5-benzoyl-1,2-dihydro-3h-pyrrolooe1,2-aaa-pyrrol-1-carboxylsyrer eller estere eller salte deraf til anvendelse som mellemprodukter ved fremstilling af tilsvarende (dl)- eller (1)-carboxylsyrederivater
DK170581A (da) Fremgangsmaade til fremstilling af dihydro-astriazino-(5,6-c) quinolin-derivater eller deres farmaceutisk acceptable syreadditionssalte

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8302171-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8302171-7

Format of ref document f/p: F